List of Tables
Table 1. Myotonic Dystrophy Drug CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
Table 2. Myotonic Dystrophy Drug Market Trends
Table 3. Myotonic Dystrophy Drug Market Drivers
Table 4. Myotonic Dystrophy Drug Market Challenges
Table 5. Myotonic Dystrophy Drug Market Restraints
Table 6. Global Myotonic Dystrophy Drug Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. India Myotonic Dystrophy Drug Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Myotonic Dystrophy Drug Sales Growth Rate (CAGR) by Distribution Channel: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. India Myotonic Dystrophy Drug Sales Growth Rate (CAGR) by Distribution Channel: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Key Manufacturers of Myotonic Dystrophy Drug, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Myotonic Dystrophy Drug Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Myotonic Dystrophy Drug Revenue Share by Manufacturer, 2018-2023
Table 13. Global Myotonic Dystrophy Drug Sales by Manufacturer, (K Unit), 2018-2023
Table 14. Global Myotonic Dystrophy Drug Sales Share by Manufacturer, 2018-2023
Table 15. Global Myotonic Dystrophy Drug Price by Manufacturer (2018-2023) & (USD$/Unit)
Table 16. Global Myotonic Dystrophy Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Myotonic Dystrophy Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myotonic Dystrophy Drug as of 2022)
Table 18. Global Key Manufacturers of Myotonic Dystrophy Drug, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Myotonic Dystrophy Drug, Product Offered and Application
Table 20. Global Key Manufacturers of Myotonic Dystrophy Drug, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Myotonic Dystrophy Drug in India, Ranked by Revenue (2022) & (US$ million)
Table 23. India Myotonic Dystrophy Drug Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Myotonic Dystrophy Drug Revenue Share by Players, (2018-2023)
Table 25. India Myotonic Dystrophy Drug Sales by Players, (K Unit), (2018-2023)
Table 26. India Myotonic Dystrophy Drug Sales Share by Players, (2018-2023)
Table 27. Global Myotonic Dystrophy Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 28. Global Myotonic Dystrophy Drug Sales in Volume by Region (2018-2023) & (K Unit)
Table 29. Global Myotonic Dystrophy Drug Sales in Volume Forecast by Region (2024-2029) & (K Unit)
Table 30. Global Myotonic Dystrophy Drug Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Myotonic Dystrophy Drug Sales in Value Forecast by Region (2024-2029) & (US$ Million)
Table 32. Americas Myotonic Dystrophy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. Americas Myotonic Dystrophy Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Myotonic Dystrophy Drug Sales in Value by Country (2024-2029) & (US$ Million)
Table 35. Americas Myotonic Dystrophy Drug Sales in Volume by Country (2018-2023) & (K Unit)
Table 36. Americas Myotonic Dystrophy Drug Sales in Volume by Country (2024-2029) & (K Unit)
Table 37. EMEA Myotonic Dystrophy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. EMEA Myotonic Dystrophy Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Myotonic Dystrophy Drug Sales in Value by Country (2024-2029) & (US$ Million)
Table 40. EMEA Myotonic Dystrophy Drug Sales in Volume by Country (2018-2023) & (K Unit)
Table 41. EMEA Myotonic Dystrophy Drug Sales in Volume by Country (2024-2029) & (K Unit)
Table 42. APAC Myotonic Dystrophy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. APAC Myotonic Dystrophy Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Myotonic Dystrophy Drug Sales in Value by Country (2024-2029) & (US$ Million)
Table 45. APAC Myotonic Dystrophy Drug Sales in Volume by Country (2018-2023) & (K Unit)
Table 46. APAC Myotonic Dystrophy Drug Sales in Volume by Country (2024-2029) & (K Unit)
Table 47. Lupin Company Information
Table 48. Lupin Description and Business Overview
Table 49. Lupin Myotonic Dystrophy Drug Sales (K Unit), Revenue (US$ Million), Price (USD$/Unit) and Gross Margin (2018-2023)
Table 50. Lupin Myotonic Dystrophy Drug Product
Table 51. Lupin Recent Development
Table 52. Teva Company Information
Table 53. Teva Description and Business Overview
Table 54. Teva Myotonic Dystrophy Drug Sales (K Unit), Revenue (US$ Million), Price (USD$/Unit) and Gross Margin (2018-2023)
Table 55. Teva Myotonic Dystrophy Drug Product
Table 56. Teva Recent Development
Table 57. ANI Pharmaceuticals Company Information
Table 58. ANI Pharmaceuticals Description and Business Overview
Table 59. ANI Pharmaceuticals Myotonic Dystrophy Drug Sales (K Unit), Revenue (US$ Million), Price (USD$/Unit) and Gross Margin (2018-2023)
Table 60. ANI Pharmaceuticals Myotonic Dystrophy Drug Product
Table 61. ANI Pharmaceuticals Recent Development
Table 62. Mylan Company Information
Table 63. Mylan Description and Business Overview
Table 64. Mylan Myotonic Dystrophy Drug Sales (K Unit), Revenue (US$ Million), Price (USD$/Unit) and Gross Margin (2018-2023)
Table 65. Mylan Myotonic Dystrophy Drug Product
Table 66. Mylan Recent Development
Table 67. Novartis Company Information
Table 68. Novartis Description and Business Overview
Table 69. Novartis Myotonic Dystrophy Drug Sales (K Unit), Revenue (US$ Million), Price (USD$/Unit) and Gross Margin (2018-2023)
Table 70. Novartis Myotonic Dystrophy Drug Product
Table 71. Novartis Recent Development
Table 72. Sun Pharma Company Information
Table 73. Sun Pharma Description and Business Overview
Table 74. Sun Pharma Myotonic Dystrophy Drug Sales (K Unit), Revenue (US$ Million), Price (USD$/Unit) and Gross Margin (2018-2023)
Table 75. Sun Pharma Myotonic Dystrophy Drug Product
Table 76. Sun Pharma Recent Development
Table 77. Mallinckrodt Company Information
Table 78. Mallinckrodt Description and Business Overview
Table 79. Mallinckrodt Myotonic Dystrophy Drug Sales (K Unit), Revenue (US$ Million), Price (USD$/Unit) and Gross Margin (2018-2023)
Table 80. Mallinckrodt Myotonic Dystrophy Drug Product
Table 81. Mallinckrodt Recent Development
Table 82. Key Raw Materials Lists
Table 83. Raw Materials Key Suppliers Lists
Table 84. Myotonic Dystrophy Drug Customers List
Table 85. Myotonic Dystrophy Drug Distributors List
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Myotonic Dystrophy Drug Product Picture
Figure 2. Global Myotonic Dystrophy Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Myotonic Dystrophy Drug Market Size 2018-2029 (US$ Million)
Figure 4. Global Myotonic Dystrophy Drug Sales 2018-2029 (K Unit)
Figure 5. India Myotonic Dystrophy Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 6. India Myotonic Dystrophy Drug Market Size 2018-2029 (US$ Million)
Figure 7. India Myotonic Dystrophy Drug Sales 2018-2029 (K Unit)
Figure 8. India Myotonic Dystrophy Drug Market Share in Global, in Value (US$ Million) 2018-2029
Figure 9. India Myotonic Dystrophy Drug Market Share in Global, in Volume (K Unit) 2018-2029
Figure 10. Myotonic Dystrophy Drug Report Years Considered
Figure 11. Product Picture of Sodium Channel Blocker
Figure 12. Product Picture of Tricyclic Antidepressant
Figure 13. Product Picture of Other
Figure 14. Global Myotonic Dystrophy Drug Market Share by Type in 2022 & 2029
Figure 15. Global Myotonic Dystrophy Drug Sales in Value by Type (2018-2029) & (US$ Million)
Figure 16. Global Myotonic Dystrophy Drug Sales Market Share in Value by Type (2018-2029)
Figure 17. Global Myotonic Dystrophy Drug Sales by Type (2018-2029) & (K Unit)
Figure 18. Global Myotonic Dystrophy Drug Sales Market Share in Volume by Type (2018-2029)
Figure 19. Global Myotonic Dystrophy Drug Price by Type (2018-2029) & (USD$/Unit)
Figure 20. India Myotonic Dystrophy Drug Market Share by Type in 2022 & 2029
Figure 21. India Myotonic Dystrophy Drug Sales in Value by Type (2018-2029) & (US$ Million)
Figure 22. India Myotonic Dystrophy Drug Sales Market Share in Value by Type (2018-2029)
Figure 23. India Myotonic Dystrophy Drug Sales by Type (2018-2029) & (K Unit)
Figure 24. India Myotonic Dystrophy Drug Sales Market Share in Volume by Type (2018-2029)
Figure 25. India Myotonic Dystrophy Drug Price by Type (2018-2029) & (USD$/Unit)
Figure 26. Product Picture of Hospital Pharmacy
Figure 27. Product Picture of Retail Pharmacy
Figure 28. Product Picture of Other
Figure 29. Global Myotonic Dystrophy Drug Market Share by Distribution Channel in 2022 & 2029
Figure 30. Global Myotonic Dystrophy Drug Sales in Value by Distribution Channel (2018-2029) & (US$ Million)
Figure 31. Global Myotonic Dystrophy Drug Sales Market Share in Value by Distribution Channel (2018-2029)
Figure 32. Global Myotonic Dystrophy Drug Sales by Distribution Channel (2018-2029) & (K Unit)
Figure 33. Global Myotonic Dystrophy Drug Sales Market Share in Volume by Distribution Channel (2018-2029)
Figure 34. Global Myotonic Dystrophy Drug Price by Distribution Channel (2018-2029) & (USD$/Unit)
Figure 35. India Myotonic Dystrophy Drug Market Share by Distribution Channel in 2022 & 2029
Figure 36. India Myotonic Dystrophy Drug Sales in Value by Distribution Channel (2018-2029) & (US$ Million)
Figure 37. India Myotonic Dystrophy Drug Sales Market Share in Value by Distribution Channel (2018-2029)
Figure 38. India Myotonic Dystrophy Drug Sales by Distribution Channel (2018-2029) & (K Unit)
Figure 39. India Myotonic Dystrophy Drug Sales Market Share in Volume by Distribution Channel (2018-2029)
Figure 40. India Myotonic Dystrophy Drug Price by Distribution Channel (2018-2029) & (USD$/Unit)
Figure 41. Americas Myotonic Dystrophy Drug Sales in Volume Growth Rate 2018-2029 (K Unit)
Figure 42. Americas Myotonic Dystrophy Drug Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 43. Americas Myotonic Dystrophy Drug Sales by Type (2018-2029) & (K Unit)
Figure 44. Americas Myotonic Dystrophy Drug Sales Market Share in Volume by Type (2018-2029)
Figure 45. Americas Myotonic Dystrophy Drug Sales by Distribution Channel (2018-2029) & (K Unit)
Figure 46. Americas Myotonic Dystrophy Drug Sales Market Share in Volume by Distribution Channel (2018-2029)
Figure 47. United States Myotonic Dystrophy Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 48. Canada Myotonic Dystrophy Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 49. Mexico Myotonic Dystrophy Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Myotonic Dystrophy Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 51. EMEA Myotonic Dystrophy Drug Sales in Volume Growth Rate 2018-2029 (K Unit)
Figure 52. EMEA Myotonic Dystrophy Drug Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 53. EMEA Myotonic Dystrophy Drug Sales by Type (2018-2029) & (K Unit)
Figure 54. EMEA Myotonic Dystrophy Drug Sales Market Share in Volume by Type (2018-2029)
Figure 55. EMEA Myotonic Dystrophy Drug Sales by Distribution Channel (2018-2029) & (K Unit)
Figure 56. EMEA Myotonic Dystrophy Drug Sales Market Share in Volume by Distribution Channel (2018-2029)
Figure 57. Europe Myotonic Dystrophy Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 58. Middle East Myotonic Dystrophy Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 59. Africa Myotonic Dystrophy Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 60. China Myotonic Dystrophy Drug Sales in Volume Growth Rate 2018-2029 (K Unit)
Figure 61. China Myotonic Dystrophy Drug Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 62. China Myotonic Dystrophy Drug Sales by Type (2018-2029) & (K Unit)
Figure 63. China Myotonic Dystrophy Drug Sales Market Share in Volume by Type (2018-2029)
Figure 64. China Myotonic Dystrophy Drug Sales by Distribution Channel (2018-2029) & (K Unit)
Figure 65. China Myotonic Dystrophy Drug Sales Market Share in Volume by Distribution Channel (2018-2029)
Figure 66. APAC Myotonic Dystrophy Drug Sales in Volume Growth Rate 2018-2029 (K Unit)
Figure 67. APAC Myotonic Dystrophy Drug Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 68. APAC Myotonic Dystrophy Drug Sales by Type (2018-2029) & (K Unit)
Figure 69. APAC Myotonic Dystrophy Drug Sales Market Share in Volume by Type (2018-2029)
Figure 70. APAC Myotonic Dystrophy Drug Sales by Distribution Channel (2018-2029) & (K Unit)
Figure 71. APAC Myotonic Dystrophy Drug Sales Market Share in Volume by Distribution Channel (2018-2029)
Figure 72. Japan Myotonic Dystrophy Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 73. South Korea Myotonic Dystrophy Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 74. China Taiwan Myotonic Dystrophy Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 75. Southeast Asia Myotonic Dystrophy Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 76. India Myotonic Dystrophy Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 77. Myotonic Dystrophy Drug Value Chain
Figure 78. Myotonic Dystrophy Drug Production Process
Figure 79. Channels of Distribution
Figure 80. Distributors Profiles
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
